Matching geography Reports matching your search in: Join Alert Me now!Receive bi-weekly email alerts on new market research Sign up today!
|
Regulation & Bioethics: market research reports
Find the information you need on regulation & bioethics in the biotechnology and research industry. Our collection of market research reports provides insights into product and market trends, analyses, opportunities, projections, sales, and marketing strategies. Specifics on market share, segmentation, size, and growth in the US and global markets are also featured.
Regulation & Bioethics market research reports and industry analysis
|
|
$4,650.00
|
Global Biobanking Market 2011-2015
8/9/2012 | published by: Infiniti Research Limited
... chronic diseases. The Global Biobanking market has also been witnessing the trend of an increasing number of mergers and acquisitions among vendors. However, the lack of standardized and high-quality human biospecimens could pose a challenge ...
|
more...
|
$1,500.00
|
|
|
$880.00
|
Biobanks - 2012 Year Book
7/10/2012 | published by: GBI Research
... major biobanks. The report provides information on population-based biobanks, disease based biobanks, brain biobanks, stem cell biobanking, twin registries, children biobanks and many national biobanks. It also provides comprehensive analysis of funding, harmonization, the cost ...
|
more...
|
$3,500.00
|
Biobanking for Medicine: Technology and Market 2012-2022
12/13/2011 | published by: Visiongain
... levels to 2022. Our study gives you business research, analysis and opinion for applications in medical research, pharmaceuticals and diagnostics. How will the biobanking industry perform? Receive forecasts for human tissue banking, stem cell banking, ...
|
more...
|
$2,739.00
|
FDA Reforms Fuel the Biotech Industry Growth
11/30/2011 | published by: GlobalData
... on the current scenario of biotechnology industry.The report provides insights on the hurdles faced by the biotech industry in the past. Most importantly, the report provides valuable insights on the FDA reforms that are helping ...
|
more...
|
$500.00
|
|
|
$3,090.00
|
|
|
$3,360.00
|
|
|
$3,180.00
|
|
|
$3,630.00
|
|
|
$2,910.00
|
Biobanks
9/1/2011 | published by: Global Industry Analysts
... through 2017. Also, a six-year historic analysis is provided for these markets. The report profiles 251 companies including many key and niche players such as Service Providers - Asterand PLC, CBR Systems, Inc., Cord Blood ...
|
more...
|
$4,200.00
|
Conference Documentation: Biobanking
7/12/2011 | published by: SMI Publishing, Ltd
... With a key focus on bridging the gap between the world’s leading academia and the pharma industry, Biobanking provides the perfect forum to successfully build essential frameworks for future research and drug development. Developing communication ...
|
more...
|
$800.00
|
Biobanking: Technologies and Global Markets
6/1/2011 | published by: BCC Research
... breakdown of the markets that will cover the U.S., the European Union, Asia, and the rest of the world Examinations of applications detailed by Biomarker Identification, Recurrence Risk, Sample Storage, Predisposition Risk, and Trial Effectiveness ...
|
more...
|
$5,450.00
|
Biobanks - 2011 Yearbook
3/1/2011 | published by: GBI Research
... world. The report provides information on the population-based biobanks, disease based biobanks, brain biobanks, stem cell biobanking, twin registries, children biobanks and many national biobanks. This report provides comprehensive analysis of funding, harmonization, cost of ...
|
more...
|
$3,500.00
|
US Regulatory Trends During 2010: A Rapidly Changing Environment
1/21/2011 | published by: Business Monitor International
... registrations, BMI notes that five potential blockbusters received approval during 2010, highlighting promising revenue growth opportunities for the drugmakers concerned: Genentech, Novo Nordisk, Amgen, Novartis and Dendreon. Of the potentially new blockbuster drugs approved, most ...
|
more...
|
$580.00
|
Benchmarking Drug Safety and Pharmacovigilance
3/1/2010 | published by: Cutting Edge Information
... and even some more recently in 2010 — have prompted the pharma industry to invest more in drug safety. Beyond changes to investments and added resources, companies are beginning to regard drug safety in more ...
|
more...
|
$7,695.00
|
|
|
$3,500.00
|
|
|
$3,835.00
|
|
|
$2,755.66
|
|
|
$599.00
|
|
|
$3,835.00
|
Outlook for Predictive Safety Technologies
11/1/2006 | published by: CHI Insight Pharma Reports
... not present safety problems serious enough to warrant termination. Outlook for Predictive Safety Technologies, a new CHA Advances report, surveys the latest developments in discovery-stage and preclinical predictive safety assessment tools—from in silico methods for ...
|
more...
|
$2,750.00
|
Good Manufacturing Practices (3rd Edition)
7/1/2006 | published by: Drug and Market Development Publishing
... amendment covering an exemption for investigational drugs in Phase 1 studies. The guide is addressed particularly to smaller sized companies, perhaps those with their first new drug, working on this extra challenge to their capabilities.
|
more...
|
$795.00
|
U.S. Select Cell Culture Markets
6/9/2003 | published by: Frost & Sullivan
... rights activists’ concerns regarding the usage of animal-based serums for cell cultures, is driving development of select cell culture products. Growing preference for poultry over beef in the United States has also adversely affected the ...
|
more...
|
$3,950.00
|
|
